文献速递血栓与止血

脂结合凝血因子VIII的结构测定

Structural determination of lipid-bound factor VIII.
PubMed 文献 · J Thromb Haemost · 2026-05-26

本研究建立了一种可重复的方法用于膜结合凝血因子的结构测定,利用甲基化支链脂质补偿膜平面性并结合冷冻电镜,分别解析了前辅因子FVIII在纳米圆盘和脂质体膜上的结构,分辨率达3.46和3.56 Å。结构分析揭示FVIII以倾斜对接方向结合膜,C2域为主要锚定,C1域为次要系链,从结构上解释了C2界面突变临床严重性高于C1表面突变。

要点

  • 甲基化支链脂质可实现膜相关凝血因子的快速高分辨率结构表征。
  • FVIII以倾斜方向结合膜,C2域为主要锚定,C1域为次要系链。
  • C2界面突变临床严重性高与其主要锚定作用的结构基础相关。

核心结论

  • 甲基化支链脂质结合冷冻电镜可快速高分辨率解析膜结合凝血因子结构。
  • FVIII-脂质界面结构为tenase复合物组装研究提供基准模板。

研究设计与样本

  • 使用甲基化支链脂质补偿膜平面性,采用冷冻电镜解析FVIII与脂质结合结构。
  • 分别在纳米圆盘和脂质体膜上解析前辅因子FVIII结构。

主要发现

  • 前辅因子FVIII在纳米圆盘和脂质体膜上的冷冻电镜结构分辨率分别为3.46和3.56 Å。
  • FVIII以倾斜对接方向结合膜,C2域为主要锚定,C1域为次要系链。
  • 该空间排布从结构上解释C2界面突变临床严重性高于C1表面突变。

临床怎么用

  • 为未来tenase复合物组装研究提供FVIII-脂质界面的基准模板。
  • 甲基化支链脂质方法可用于膜相关凝血因子的高分辨率结构表征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Coagulation factor (F)VIII is the inactive precursor of FVIIIa, an essential component of the intrinsic tenase complex. Despite numerous structures of recombinant FVIII in solution, the structural basis of the procofactor-membrane interface remains poorly defined. Traditional liposome platforms require special grids and often suffer from heterogeneous particle distribution and overcrowding, precluding high-resolution single-particle analysis, while membrane mimetics-nanodiscs-are too planar, posing significant biophysical challenges. OBJECTIVES: This study established a reproducible methodology for structural determination of membrane-bound coagulation factors and resolve the procofactor FVIII-lipid interface. METHODS: We used methylated branched lipids to compensate for membrane planarity and used cryoelectron microscopy to solve the structure of FVIII bound to lipids. RESULTS: We resolved the cryoelectron microscopy structure of procofactor FVIII on nanodiscs and liposomes lipid membranes at 3.46 and 3.56 Å, respectively. Structural analysis reveals a definitive tilted docking orientation where both C domains mediate shallow interfacial insertion, with the C2 domain acting as the primary anchor and the C1 domain serving as a secondary tether. This spatial arrangement structurally explains the high clinical severity of C2 interface mutations compared with more moderate C1 surface mutations. CONCLUSION: Methylated branched lipids enable rapid, high-resolution characterization of membrane-associated clotting factors. This structure provides the first definitive template for the FVIII-lipid interface, serving as a benchmark for future studies on tenase complex assembly.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Mohammed BM. Structural determination of lipid-bound factor VIII. J Thromb Haemost. 2026. PMID: 42202884. doi:10.1016/j.jtha.2026.05.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。